Welcome to the ValueWiki ONCOLYTICS BIOTECH INC. (ONC:CA) article! Register for free or click the "edit" link to contribute!

ONCOLYTICS BIOTECH INC. (ONC:CA)

From ValueWiki

Jump to: navigation, search

Launch Chat Window

TSX \ Life Sciences \ Biotechnology & Pharmaceuticals

ONCOLYTICS BIOTECH INC. is a biotechnology company focused on the development of a human reovirus-based product, REOLYSIN, as a potential cancer therapeutic.Summary from Toronto Stock Exchange

1 Company Analysis
2 News Feed
3 Risks
4 Research Links
5 Notes

Today

Max

[edit]

Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.^[1] Be bold!

[edit]

News Feed

12/22/08 12:12 pm	Oncolytics Biotech Inc. Appoints Dr. Matt Coffey as Chief Operating Officer (CNW Group)
12/18/08 5:12 pm	Oncolytics Biotech Inc. Amends Terms of Previously Issued Broker Warrants (CNW Group)
12/18/08 1:12 pm	Oncolytics Biotech Inc. Completes Patient Enrolment in Two U.K. REOLYSIN(R) Combination Therapy Clinical Trials (CNW Group)
12/11/08 7:12 am	Oncolytics Biotech Inc.'s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study (CNW Group)
11/18/08 7:11 am	Oncolytics Biotech Inc. Announces Issuance of 30th U.S. Patent (CNW Group)
11/14/08 7:11 am	Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting (CNW Group)
11/06/08 4:11 pm	Media Advisory - Oncolytics Biotech Inc. to Present at Rodman & Renshaw 10th Annual Healthcare Conference (CNW Group)
11/06/08 12:11 pm	Oncolytics Biotech Inc. Investigators Present Interim U.S. REOLYSIN(R) Phase II Sarcoma Trial Data (CNW Group)
11/05/08 3:11 pm	Oncolytics Biotech Inc. Announces U.S. Phase II Sarcoma Clinical Trial Conference Call (CNW Group)
11/04/08 4:11 pm	Oncolytics Biotech Inc. Announces 2008 Third Quarter Results (CNW Group)